- Open Access
Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors
© Wang et al; licensee BioMed Central Ltd. 2010
- Received: 29 November 2009
- Accepted: 17 March 2010
- Published: 17 March 2010
Human herpes virus 8 (HHV-8) is the etiologic agent associated with development of classical, AIDS-related, iatrogenic, and endemic Kaposi's sarcoma (KS). Several studies provide strong evidence that HHV-8 can be transmitted by blood transfusion. We evaluated the seroprevalence and potential risk factors of HHV-8 infection in blood donors in one region. We surveyed HHV-8 infection among 4461 blood donors in Xinjiang, China, a unique endemic area for HHV-8 and KS.
The HHV-8 seroprevalence was higher in local minority groups which comprise most KS cases in China, than in Han people. HHV-8 prevalence was 18.6% in the Han ethnic group, 25.9% in Uygur subjects, 29.2% in Kazak subjects, 36.8% in Mongolian subjects, and 21.9% in other ethnic groups. In several subgroups, the time of donation of whole blood seemed to be a risk factor. In HHV-8-seropositive subjects, a larger fraction of local minorities (23.9%) had high HHV-8 titers than that of Han subjects (9.2%). HHV-8 infection was associated with ethnicity and residence.
HHV-8 seroprevalence was significantly high among blood donors in Xinjiang, where the prevalence of KS correlates with HHV-8 prevalence and titers in Uygur and Kazak ethnic groups. Blood exposure represented by the frequency of blood donation indicated a possible blood-borne transmission route of HHV-8 in Xinjiang. Detecting anti-HHV-8 antibodies before donation in this region is therefore important.
- Blood Donor
- Local Minority
- Mongolian Group
- Uygur Group
- Kazak Group
Human herpes virus 8 (HHV-8) is the etiologic agent associated with the development of classical, AIDS-related, iatrogenic, and endemic Kaposi's sarcoma (KS) [1, 2]. HHV-8 is also associated with lymphoproliferative diseases, including primary effusion lymphomas and multicentric Castleman's disease [3, 4]. Emerging evidence suggests that HHV-8 may be transmitted through sexual contact [5, 6], saliva , and blood transfusion [8–10]. In the USA, where HHV-8 seroprevalence is low (<10%), HHV-8 is spread by the sexual route, at least among homosexual men [5, 6]. In regions or countries with high HHV-8 seroprevalence (>25%), HHV-8 infection increases throughout childhood, suggesting that transmission occurs through saliva or other horizontal routes [11–13]. Of note, HHV-8 infection has been observed in patients who received non-leukocyte-reduced blood . Infectious viruses or viral DNA have been identified from blood donors in the USA and Africa [14, 15]. HHV-8 infection has been observed in patients receiving blood transfusions in Uganda, thereby indicating blood-borne transmission of HHV-8 [9, 10].
HHV-8 seroprevalence among blood donors varies between different regions. HHV-8 prevalence ranges from 0.2% in Japan, 0-15% in the USA and the UK, up to >50% in some African countries [16, 17]. There is a wide range of variations in HHV-8 infection in South America . A few studies focusing on small study populations have been carried out in China. In the inland areas of China, HHV-8 seroprevalence in general population was <8% [19, 20]. In Xinjiang, in the northwest of China, HHV-8 seroprevalence ranged from 12.5% to 48% depending on different populations [21–24]. The mode of HHV-8 transmission remains undefined, but the unique pattern of HHV-8 infection in this geographic region correlated well with an increased incidence of KS [21, 22, 24].
Demographic patterns of HHV-8 seroprevalence among blood donors
Sociodemographic characteristics by HHV-8 seroprevalence
Number of subjects (%)
HHV-8 sero-positivity (%)
OR (95% CI)
Age group (years)
Technical Secondary School
Senior High School
Junior High School
Outside of Xinjiang
HHV-8 seroprevalence by blood donor-associated behaviors
Number of subjects (%)
HHV-8 sero-positivity (%)
OR (95% CI)
Type of blood donation
Time of donation of whole blood
Time of donation of blood components
Assessment of risk factors
Analyses by risk factor
OR (95% CI)
Time of donation of whole blood
HHV-8 antibody titers in HHV-8-positive individuals
The present study was the first large-scale survey of HHV-8 seroprevalence in blood donors in China. Recent reports showed that HHV-8 seroprevalence was 7.3% in Liaonin province and 5.7% in Shandong province among healthy blood donors [19, 25]. These studies focused on the Han ethnic group, and the study population was small. A study in the Han ethnic group in Hubei province revealed that HHV-8 seroprevalence was 5.2% . The prevalence of HHV-8 infection reported in these studies was similar to those among the adult population in North America [6, 14, 26]. These observations suggest that HHV-8 seroprevalence in China was, in general, low. The Xinjiang area, located in the northwest of China, exhibited a distinct pattern. We noted that HHV-8 seroprevalence was relatively high in the Han ethnic group living in Xinjiang: 18.6% of blood donors were HHV-8 positive. Moreover, HHV-8 seroprevalence was 17.7% among the 1140 non-residential Han ethnic group who migrated to Xinjiang from inland areas. Thus, an elevated HHV-8 seroprevalence in the Han ethnic group in Xinjiang province implies an association of HHV-8 infection with the living environment. These potential factors which contribute to the differences within the same ethnic group suggest an increased opportunity for members of the Han ethnic group to have close contact with highly infected populations. And the relatively low level of public health in Xinjiang province due to the economic situation in this region may benefit the spread or transmission of HHV-8, but this hypothesis needs conformation. The precise impact of being resident in Xinjiang on HHV-8 infection could not be ascertained because of the cross-sectional nature of the present study.
The present study suggested that HHV-8 seroprevalence was associated with ethnicity but not with sex, age, marital status, occupation, educational level, blood type, and time of donation of blood components. Among blood donors, HHV-8 seroprevalence was 18.6% in the Han group, 25.9% in the Uygur group, 29.2% in the Kazak group, and 36.8% in the Mongolian group. When combined, the mean prevalence of HHV-8 infection in local minorities was 30.6%. Compared with Han subjects living in Xinjiang, the elevated HHV-8 seroprevalence in local minorities was significant. Hence, what was the basis for the observed differences? It is known that local minorities have resided in Xinjiang for generations, and that they have unique cultural practices. An intriguing possibility is that different cultural practices or social behaviors may play a part in HHV-8 infection. Alternatively, genetic factors may affect the susceptibility to HHV-8 infection. Additional studies are required to address these issues.
Several studies have demonstrated that HHV-8 seroprevalence is correlated with the occurrence of KS in Europe and Africa [27–30]. In Ghana and Egypt, a high prevalence of HHV-8 does not correlate well with KS onset [11, 31]. HHV-8 seroprevalence is high among Amerindians in Brazil, French Guiana and Ecuador [32–34]. Nonetheless, KS has not been reported for these populations. The present study revealed that HHV-8 seroprevalence was higher in Han subjects residing in Xinjiang than in the inland areas of China. Furthermore, it was higher in local minority groups than in Han subjects. HHV-8 prevalence remained high in blood donors residing in Xinjiang, but classical KS and AIDS-related KS were observed only among local minority groups [21, 22]. Taken together, these data support the hypothesis that additional factors other than HHV-8 may be involved in KS development.
Several researchers reported blood-borne transmission of HHV-8 among a large cohort of drug users, or prospective studies on blood-transfusion recipients [8, 10]. The present study was in accordance with these studies because it established a positive relationship between an increasing prevalence of infection with the corresponding frequency of donation of whole blood. To a certain extent, the time of donation represents the opportunity of blood exposure. In China, laws pertaining to donation of whole blood were passed in 1992. Before 1992, non-standard protocols for blood collection, and absence of instruments and materials were common. These conditions could increase the prevalence of HHV-8 infection by blood exposure. A possible explanation for the contradictory results in the univariate analysis with respect to the time of donation of blood components may be due to the small number of samples in each group or undetermined factors.
There was a difference in HHV-8 antibody titers among HHV-8-seropositive individuals in the present study. Specifically, a larger fraction of local minorities had high HHV-8 antibody titers than Han subjects. This was evident in the Uygur and Kazak ethnic groups. Whether this reflects enhanced replication of HHV-8 or enhanced immune responses is not clear. Notably, KS patients are seen in Uygur and Kazak ethnic groups in Xinjiang hospitals [21, 22]. The patients are typically elderly men who have multiple nodular lesions in the lower or upper extremities. Intriguingly, KS patients tend to be younger among those who are also infected with HIV. Hence, high HHV-8 antibody titers in Uygur and Kazak groups appeared to correlate with the development of KS in these ethnic groups.
HHV-8 seroprevalence was significantly high in blood donors from Xinjiang. A critical question relevant to public health is if HHV-8 is transmitted through blood transfusion in the Xinjiang area. Several studies in the USA and Africa suggest an association between HH-8 infection with blood transfusion Error! Reference source not found. Given that HHV-8 seroprevalence in the Xinjiang area is high, assessing the risk of HHV-8 transmission via blood transfusion in future studies is essential.
Ethical approval of the study protocol
The present study was approved by the Institutional Ethics Committee of the First Teaching Hospital of Xinjiang Medical University (Urumqi, Xinjiang, China). Written informed consent was obtained from all subjects, and patient confidentiality was ensured.
A cross-sectional study was designed to assess the seroprevalence of HHV-8 infection among blood donors in Xinjiang, China. Serum samples, collected and deposited from all five blood banks belonging to Xinjiang Blood Center between August 2006 and May 2007, were analyzed. These samples were derived from 4832 blood donors belonging to different ethnic groups: Han, Uygur, Kazak, Mongolian, and others. All samples went through a standard screening for HBV, HCV, HIV, and syphilis. A questionnaire regarding age, sex, ethnicity, marital status, education and residence was collected. Of 4832 blood donors, 4461 blood donors completed all sections of the questionnaire. Serum samples were centrifuged and stored at -80°C before HHV-8 serologic testing.
The coded serum specimens were tested for HHV-8 antigens of ORF73, ORF65 and K8.1 using enzyme-linked immunosorbent assays as described 22,24Error! Reference source not found. This assay has a sensitivity of 82% and a specificity of 96% 22 . Briefly, viral antigen-coated plates were incubated with serum samples diluted at 1:100. This was followed by incubation with goat anti-human immunoglobulins (including IgG) conjugated with horseradish peroxidase (HRP; Tago Immunologicals). The mean optical density at 450 nm was determined. Controls included serum samples derived from KS patients and HHV-8-negative individuals. Based on the assays from control groups, the HHV-8-positive cutoff was set to the value that was three-times that of the negative control. The HHV-8 high titer was set to the value that was more than five-times that of the negative control.
All statistical analyses were carried out using SPSS software version 12.0 (SPSS Incorporated, Chicago, IL, USA). The univariate analysis of categorical variables was evaluated by #2 test with P < 0.05 being considered significant. Associations revealed by OR and P were evaluated at a CI of 95%. Multivariate logistic regression analysis was carried out to control for confounding factors. CI was calculated based on coefficients and standard errors from the logistic model. Seropositive prevalence and risk factors were compared between groups.
This work was supported by the Youth Funds of Xinjiang Autonomous Region (grant number 2009211B17) and the Joint Funds of the National Natural Science Foundation of China (30760228).
- Chang Y, Cesarman E, Pessin MS, et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266: 1865-1869. 10.1126/science.7997879PubMedView ArticleGoogle Scholar
- Schalling M, Ekman M, Kaaya EE, et al.: A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995, 1: 707-708. 10.1038/nm0795-707PubMedView ArticleGoogle Scholar
- Cesarman E, Chang Y, Moore PS, et al.: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332: 1186-1191. 10.1056/NEJM199505043321802PubMedView ArticleGoogle Scholar
- Soulier J, Grollet L, Oksenhendler E, et al.: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86: 1276-1280.PubMedGoogle Scholar
- Martin JN, Ganem DE, Osmond DH, et al.: Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338: 948-954. 10.1056/NEJM199804023381403PubMedView ArticleGoogle Scholar
- Engels EA, Atkinson JO, Graubard BI, et al.: Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007, 196: 199-207. 10.1086/518791PubMedView ArticleGoogle Scholar
- Pauk J, Huang ML, Brodie SJ, et al.: Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000, 343: 1369-1377. 10.1056/NEJM200011093431904PubMedView ArticleGoogle Scholar
- Dollard SC, Nelson KE, Ness PM, et al.: Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion 2005, 45: 500-503. 10.1111/j.0041-1132.2005.04334.xPubMedView ArticleGoogle Scholar
- Mbulaiteye SM, Biggar RJ, Bakaki PM, et al.: Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst 2003, 95: 1330-1335.PubMedView ArticleGoogle Scholar
- Hladik W, Dollard SC, Mermin J, et al.: Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006, 355: 1331-1338. 10.1056/NEJMoa055009PubMedView ArticleGoogle Scholar
- Andreoni M, El-Sawaf G, Rezza G, et al.: High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst 1999, 91: 465-469. 10.1093/jnci/91.5.465PubMedView ArticleGoogle Scholar
- Brayfield BP, Phiri S, Kankasa C, et al.: Postnatal human herpesvirus 8 and human immunodeficiency virus type 1 infection in mothers and infants from Zambia. J Infect Dis 2003, 187: 559-568. 10.1086/367985PubMedView ArticleGoogle Scholar
- de Souza VA, Sumita LM, Nascimento MC, et al.: Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. J Infect Dis 2007, 196: 844-852. 10.1086/520549PubMedPubMed CentralView ArticleGoogle Scholar
- Blackbourn DJ, Ambroziak J, Lennette E, et al.: Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997, 349: 609-611. 10.1016/S0140-6736(96)10004-0PubMedView ArticleGoogle Scholar
- Belec L, Cancre N, Hallouin MC, et al.: High prevalence in Central Africa of blood donors who are potentially infectious for human herpesvirus 8. Transfusion 1998, 38: 771-775. 10.1046/j.1537-2995.1998.38898375517.xPubMedView ArticleGoogle Scholar
- Antman K, Chang Y: Kaposi's sarcoma. N Engl J Med 2000, 342: 1027-138. 10.1056/NEJM200004063421407PubMedView ArticleGoogle Scholar
- Baillargeon J, Deng JH, Hettler E, et al.: Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas. Annals Epidemiol 2001, 11: 512-518. 10.1016/S1047-2797(01)00242-3View ArticleGoogle Scholar
- Mohanna S, Portillo JA, Carriquiry G, et al.: Human herpesvirus-8 in Peruvian blood donors: a population with hyperendemic disease? Clin Infect Dis 2007, 44: 558-561. 10.1086/511044PubMedView ArticleGoogle Scholar
- Wang GQ, Xu H, Wang YK, et al.: Higher prevalence of human herpesvirus 8 DNA sequence and specific IgG antibodies in patients with pemphigus in China. J Am Acad Dermatol 2005,52(3 Pt 1):460-467. 10.1016/j.jaad.2004.10.882PubMedView ArticleGoogle Scholar
- Fang Q, Liu J, Q BZ, et al.: Seroprevalence of Kapsosi's sarcom-associated herpesvirus in the central population from Hubei provine. Viroligica Sinica 2006, 21: 97-101.Google Scholar
- Dilnur P, Katano H, Wang ZH, et al.: Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Intl 2001, 51: 845-852. 10.1046/j.1440-1827.2001.01293.xView ArticleGoogle Scholar
- He F, Wang X, He B, et al.: Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China. J Med Virol 2007, 79: 161-166. 10.1002/jmv.20730PubMedView ArticleGoogle Scholar
- Du W, Chen G, Sun H, et al.: Antibody to human herpesvirus type 8 in the general populations of Xinjiang Autonomous Region. Chinese J Exp Clin Virol 2000, 14: 44-47.Google Scholar
- Fu B, Sun F, Li B, et al.: Seroprevalence of Kaposi's Sarcoma-associated Herpesvirus and Risk Factors in Xinjiang, China. J Med Virol 2009, 81: 1422-1431. 10.1002/jmv.21550PubMedPubMed CentralView ArticleGoogle Scholar
- Mei Q, Ming ZW, Ping YX, et al.: HHV-8 seroprevalence in blood donors and HIV-positive individuals in Shandong area, China. J Infect 2007, 55: 89-90. 10.1016/j.jinf.2006.10.046PubMedView ArticleGoogle Scholar
- Kedes DH, Operskalski E, Busch M, et al.: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996, 2: 918-924. 10.1038/nm0896-918PubMedView ArticleGoogle Scholar
- Kedes DH, Ganem D, Ameli N, et al.: The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 1997, 277: 478-481. 10.1001/jama.277.6.478PubMedView ArticleGoogle Scholar
- Rezza G, Lennette ET, Giuliani M, et al.: Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Intl J Cancer 1998, 77: 361-365. 10.1002/(SICI)1097-0215(19980729)77:3<361::AID-IJC9>3.0.CO;2-MView ArticleGoogle Scholar
- Gao SJ, Kingsley L, Li M, et al.: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996, 2: 925-928. 10.1038/nm0896-925PubMedView ArticleGoogle Scholar
- Boshoff C, Weiss RA: Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Phil Trans R Soc Lon Biol Sci 2001, 356: 517-534. 10.1098/rstb.2000.0778View ArticleGoogle Scholar
- Ablashi D, Chatlynne L, Cooper H, et al.: Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Brit J Cancer 1999, 81: 893-897. 10.1038/sj.bjc.6690782PubMedPubMed CentralView ArticleGoogle Scholar
- Biggar RJ, Whitby D, Marshall V, et al.: Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 2000, 181: 1562-1568. 10.1086/315456PubMedView ArticleGoogle Scholar
- Whitby D, Marshall VA, Bagni RK, et al.: Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol 2004,85(Pt 1):155-163. 10.1099/vir.0.19465-0PubMedView ArticleGoogle Scholar
- Kazanji M, Dussart P, Duprez R, et al.: Serological and molecular evidence that human herpesvirus 8 is endemic among Amerindians in French Guiana. J Infect Dis 2005, 192: 1525-1529. 10.1086/491744PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.